Microbiome-targeting therapies in the neonatal intensive care unit: Safety and efficacy

Authors

Anna DeVeaux, Washington University School of Medicine in St. Louis
Jian Ryou, Washington University School of Medicine in St. Louis
Gautam Dantas, Washington University School of Medicine in St. Louis
Barbara B Warner, Washington University School of Medicine in St. Louis
Phillip I Tarr, Washington University School of Medicine in St. Louis

Journal

Gut Microbes

Publication Date

1-1-2023

Volume

15

Issue

1

First Page

2221758

Document Type

Open Access Publication

DOI

10.1080/19490976.2023.2221758

Rights and Permissions

DeVeaux A, Ryou J, Dantas G, Warner BB, Tarr PI. Microbiome-targeting therapies in the neonatal intensive care unit: safety and efficacy. Gut Microbes. 2023 Jan-Dec;15(1):2221758. doi: 10.1080/19490976.2023.2221758. © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

Recommended Citation

DeVeaux, Anna; Ryou, Jian; Dantas, Gautam; Warner, Barbara B; and Tarr, Phillip I, "Microbiome-targeting therapies in the neonatal intensive care unit: Safety and efficacy." Gut Microbes. 15, 1. 2221758 (2023).
https://digitalcommons.wustl.edu/oa_4/2152

Department

ICTS (Institute of Clinical and Translational Sciences)